Details of the Drug Reposition

General Information of This Drug (ID: DMOM8AL)

Drug Name
Scopolamine   DMOM8AL
Synonyms
Atroscine; Euscopol; Hyosceine; Hysco; Isoscopil; Kwells; SEE; Scop; Scopamin; Scopolaminhydrobromid; Scopos; Sereen; Tranaxine; Transcop; Triptone; Atroscine Hydrobromide; Hydroscine hydrobromide; Hyocine F hydrobromide; Hyoscine bromide; Hyoscyine hydrobromide; SCOPOLAMINE BROMIDE; Scopolamine Hyoscine; Scopolaminium bromide; Scopolammonium bromide; Tropane alkaloid; MOLI001381; NCI61806; Borrachero (TN); Burundanga (TN); Hyoscine (TN); L-Hyoscine hydrobromide; Scopoderm-TTS; Scopolamine (INN); Transderm scop (TN); Levo-duboisine (TN); Xy-, (-)-tropate (ester); (-)-Scopolamine hydrobromide trihydrate; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epo; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester); 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate
Therapeutic Class
Antispasmodics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
9 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Major depressive disorder DIS4CL3X 6A70.3 Approved [1]
Addictive disorder DIS6447M 6C50-6C5Z Approved [2]
Common cold DIS3MADM CA00 Approved [1]
Vasomotor/allergic rhinitis DISHSTQ0 CA08 Approved [1]
Peptic ulcer DISL8XZI DA61 Approved [1]
Irritable bowel syndrome DIS27206 DD91.0 Approved [1]
Mydriasis DISG7YFO LA11.62 Approved [1]
Cough DIS51FA4 MD12 Approved [1]
Nausea DIS50TOO MD90 Approved [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Indications(s)
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Motion sickness DISZ2WZW NF08.3 Withdrawn [3]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cycloplegia DIST1X9P N.A. Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
2 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Iridocyclitis DISV6UP4 N.A. Investigative [1]
Uveitis DISV0RYS 9A96.Z Investigative [1]
------------------------------------------------------------------------------------

References

1 Scopolamine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 330).
3 Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)
4 Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation